|
Ministry of Health
Central Administration for Pharmaceutical Affairs
General Directorate of Pharmaceutical Inspection
Department of Pharmacies and Warehouses Inspection
Code No. FM-IPW-07
Periodical Publication No. (21) of 2015 (Commercial Fraud)
Health Affairs Unit
Pharmaceutical Administration
Please seize and store all that can be found at the local markets and governmental units after taking all governmental storing procedures, of Sovaldi (400 mg pills) used in Hepatitis C treatment, as per the request of the original medicine importing company. The original packs of such medicine are imported and distributed by Ibis Pharma and produced by Gilead Sciences.
The original and counterfeit packs can be differentiated as follows:
|
Original Packs
|
Falsified Packs
|
|
1. State Ministry of Health registration number 2014/30008
|
1. Ministry of Health registration number is not stated
|
|
2.
|
2.
|
|
3. States Selling price L.E.14940 for a 28 pills pack
|
3. Does not state selling price
|
|
4. Longer pack
|
4. Shorter pack
|
|
5. the sentence “Gilead Access Program” is printed
|
5. Does not include this sentence
|
|
6. Shorter pack cover
|
6. Longer pack cover
|
|
7. Patch number is printed in English letters
|
7. Patch number is printed in numbers with no letters
|
|
8. The lid of the pack is shorter
|
8. The lid of the pack is longer
|
|
9. the letters “GSI” are printed on one side of the pill and the number “7977” is printed on the other
|
9. the letters and number “GXCK2” are printed on the pill includes
|
Please find attached the colored pictures that clarify the apparent differences between the original and counterfeit packs of the said medicine.
Such a publication should be distributed to all public and private hospitals located within the scope of the governorate. All legal procedures should be taken against the related pharmaceutical agency in case no purchase invoices are available and against the supplying body in case such invoices are available. We should be notified of actions taken in this concern.
Best Regards
Director, Department of Pharmacies and Warehouses Inspection
Dr. Hossam Al Din Mustafa
Director, General Directorate of Pharmaceutical Inspection
Dr. Madiha Ahmed Ibrahim
Head of Central Administration for Pharmaceutical Affairs
Dr. Hoda Abdel Khaleq
Copy to Head of Pharmacist Union Egypt
|